Skip to main content
. 2023 Aug 28;46(4):397–401. doi: 10.1016/j.htct.2023.07.007

Table 3.

Characteristics of four patients who died.

Patient number Induction regimen Complication during induction Cycle in which the patient died Complications Time of death⁎⁎ Cause of death
1 Cytarabine + daunorubicin Fusariosis 1 Typhlitis, Clostridioides difficile colitis 20 Septic shock
2 Cytarabine + daunorubicin Bacteremia viridans Streptococcus 1 Candidemia due to Candida tropicalis, septic shock 15 Septic shock
3 Cytarabine + mitoxantrone None 3 DIC related to relapse and disease progression 17 Disease progression
4 Cytarabine + daunorubicin Bacteremia CONS 2 Typhlitis 44 Disease progression

DIC = disseminated intravascular coagulation; CONS = coagulase-negative staphylococci.

⁎⁎

Time of death related to the first day of the cycle of high-dose cytarabine.